Julio García‐Suárez

Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study

Julio García‐Suárez, Javier de la Cruz, Ángel Cedillo et al. · Journal of Hematology & Oncology · 2020 · 238 citations · Full text

Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: Impact of novel therapies

Julio García‐Suárez, Dunia de Miguel, Isabel Krsnik et al. · American Journal of Hematology · 2005 · 118 citations · Full text

Immunodeficiencies, Immunology, Pathology +21

HCV‐associated thrombocytopenia: clinical characteristics and platelet response after recombinant α2b‐interferon therapy

Julio García‐Suárez, Carmen Burgaleta, Nuria Hernanz et al. · British Journal of Haematology · 2000 · 102 citations

Hepatitis C Virus, Immunology, Pathology +21

Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study

Isabel Regalado‐Artamendi, Ana Jiménez Ubieto, José‐Ángel Hernández‐Rivas et al. · HemaSphere · 2021 · 71 citations · Full text

Severe chronic autoimmune thrombocytopenic purpura is associated with an expansion of CD56+ CD3- natural killer cells subset [see comments]

Julio García‐Suárez, Alfredo Prieto, Eduardo Reyes et al. · Blood · 1993 · 53 citations · Full text